Civco Holding may soon own medical device design firm Colorado MEDtech. The two companies announced March 13 the signing of a definitive agreement for the sale of the Boulder, CO, company for $62.5 million. KRG Capital Partners and its affiliated funds
Civco Holding may soon own medical device design firm Colorado MEDtech. The two companies announced March 13 the signing of a definitive agreement for the sale of the Boulder, CO, company for $62.5 million. KRG Capital Partners and its affiliated funds control Civco Holding. Subject to shareholder approval and due diligence, the transaction is expected to close by June 30. The agreement calls for Colorado MEDtech to operate as a private corporation. It will continue developing and manufacturing equipment for the ultrasound and minimally invasive OEM and end-user markets.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.